BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12406187)

  • 21. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.
    Thompson MA; Stumph J; Henrickson SE; Rosenwald A; Wang Q; Olson S; Brandt SJ; Roberts J; Zhang X; Shyr Y; Kinney MC
    Hum Pathol; 2005 May; 36(5):494-504. PubMed ID: 15948116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease.
    Ladanyi M; Cavalchire G; Morris SW; Downing J; Filippa DA
    Am J Pathol; 1994 Dec; 145(6):1296-300. PubMed ID: 7527617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
    Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
    Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma.
    Mehrotra M; Medeiros LJ; Luthra R; Sargent RL; Yao H; Barkoh BA; Singh R; Patel KP
    Hum Pathol; 2014 Oct; 45(10):1995-2005. PubMed ID: 25128227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays.
    Gaiser T; Thorns C; Merz H; Noack F; Feller AC; Lange K
    J Hematother Stem Cell Res; 2002 Apr; 11(2):423-8. PubMed ID: 11983114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
    Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
    Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1.
    Leoncini L; Megha T; Lazzi S; Bellan C; Luzi P; Tosi P; Cevenini G; Barbini P; Ascani S; Briskomatis A; Pileri S; Kraft R; Laissue JA; Cottier H
    Int J Cancer; 1998 Jul; 77(3):408-14. PubMed ID: 9663604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker.
    ten Berge RL; Oudejans JJ; Dukers DF; Meijer JW; Ossenkoppele GJ; Meijer CJ
    Leukemia; 2001 Mar; 15(3):458-64. PubMed ID: 11237071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA content and expression of PCNA and p53 in Hodgkin's disease and Hodgkin's-like B-cell lymphoma.
    Czader M; Porwit A; Ost A; Auer G
    APMIS; 1994 Nov; 102(11):865-73. PubMed ID: 7833007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
    Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
    Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Most of CD30+ anaplastic large cell lymphoma of B cell type show a somatic mutation in the IgH V region genes.
    Kuze T; Nakamura N; Hashimoto Y; Abe M
    Leukemia; 1998 May; 12(5):753-7. PubMed ID: 9593274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma.
    Harris NL
    Semin Diagn Pathol; 1992 Nov; 9(4):304-10. PubMed ID: 1480853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
    Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
    Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large cell anaplastic Ki-1+ non-Hodgkin's lymphoma vs. Hodgkin's disease in fine needle aspiration biopsy samples.
    Bizjak-Schwarzbartl M
    Acta Cytol; 1997; 41(2):351-6. PubMed ID: 9100766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray analysis of B-cell lymphoma cell lines with the t(14;18).
    Robetorye RS; Bohling SD; Morgan JW; Fillmore GC; Lim MS; Elenitoba-Johnson KS
    J Mol Diagn; 2002 Aug; 4(3):123-36. PubMed ID: 12169673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin.
    Cohen PL; Butmarc J; Kadin ME
    Am J Clin Pathol; 1995 Jul; 104(1):50-3. PubMed ID: 7611181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.
    Weisenburger DD; Anderson JR; Diebold J; Gascoyne RD; MacLennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Armitage JO
    Am J Hematol; 2001 Jul; 67(3):172-8. PubMed ID: 11391714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.
    ten Berge RL; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Oudejans JJ; Meijer JW; Willemze R; Hilgers J; Meijer CJ
    J Clin Pathol; 2001 Dec; 54(12):933-9. PubMed ID: 11729213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.